The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope-Reference-Cited by-同舟云学术

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope

Published:2024 Issue:3 Volume:8 Page:
ISSN:2514-1775
Container-title:Rheumatology Advances in Practice
language:en
Short-container-title:

Author:

Mercer Louise¹^ORCID,Abhishek Abhishek²³^ORCID,Kavirayani Akhila⁴,Ahmed Alison⁵,Davidson Alan⁶,Foulkes Amy⁷,Jones Claire⁸,Nash Clare⁹,Rose-Parfitt Emily¹⁰,Dhillon Emmandeep¹¹,Zabate Genevieve¹²,Twohig Helen¹³^ORCID,De Vere Hope¹⁴,Scott Jennifer¹⁵,Reynolds John¹⁶^ORCID,Holmes Julia¹⁷,Hartley Karen¹⁸,Warrier Kishore¹⁹,Nowak Kataryzna²⁰^ORCID,Parsons Kate²¹,Bechman Katie²²,Bray Lisa²³,Adikari Madura²⁴,Wood Natasha²⁵,Faithfull Nicola²⁶,Gullick Nicola²⁷^ORCID,Saha Pratyasha²⁸^ORCID,Heaton Rebecca²⁹,Deepak Samundeeswari³⁰,Hider Samantha¹³³¹^ORCID,Khalid Sameena³²,Said Sanaa Suleiman³³,Ryan Sarah³⁴^ORCID,Kyle Stuart³⁵,Raghuvanshi Subhra³⁶,Tan Su-Yin³⁷,Shivamurthy Vinay³⁸,Galloway James²²^ORCID

Affiliation:

1. Department of Rheumatology, Stepping Hill Hospital, Stockport NHS Foundation Trust , Stockport, UK

2. Academic Rheumatology, City Hospital Nottingham, University of Nottingham , Nottingham, UK

3. Nottingham NIHR BRC , Nottingham, UK

4. Paediatric Rheumatology, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust , Oxford, UK

5. Department of Rheumatology, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton-Under-Lyme , UK

6. Community Rheumatology, Modality LLP , Birmingham, UK

7. Department of Dermatopharmacology, Salford Royal NHS Foundation Trust , Salford, UK

8. Medicines Management, Powys Teaching Health Board , Brecon, Powys, UK

9. Pharmacy Department, Sheffield Children’s NHS Foundation Trust , Sheffield, UK

10. Department of Rheumatology, Southmead Hospital, North Bristol NHS Trust , Bristol, UK

11. Department of Rheumatology, New Cross Hospital, Royal Wolverhampton NHS Trust , Wolverhampton, UK

12. Rheumatic Diseases Unit, Western General Hospital NHS Lothian , Edinburgh, UK

13. School of Medicine, Keele University , Keele, UK

14. Department of Rheumatology, Gloucestershire Hospitals NHS Foundation Trust , UK

15. Department of Hepatology and Gastroenterology, Stepping Hill Hospital, Stockport NHS Foundation Trust , Stockport, UK

16. Institute of Inflammation and Ageing, University of Birmingham Research Labs, Queen Elizabeth Hospital, University of Birmingham , Birmingham, UK

17. Expert by Experience, Versus Arthritis Fellowship Expert Committee Member

18. Department of Pharmacy, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle, UK

19. Paediatric and Adolescent Rheumatology, Nottingham Children’s Hospital, Nottingham University Hospitals NHS Trust , Nottingham, UK

20. Department of Rheumatology, Belfast Health and Social Care Trust , Belfast, UK

21. Expert by Experience , UK

22. Centre for Rheumatic Diseases, King’s College London , London, UK

23. Department of Paediatrics, St Richard’s Hospital , Chichester, UK

24. Department of Rheumatology, Rotherham General Hospital, Rotherham NHS Foundation Trust , Rotherham, UK

25. Brannam Medical Centre , Barnstaple, UK

26. Childhood Arthritis and Rheumatic Diseases Unit, Birmingham Children’s Hospital , Birmingham, UK

27. Department of Rheumatology, University Hospitals Coventry & Warwickshire , Coventry, UK

28. Department of Rheumatology, Norfolk and Norwich University Hospital , Norfolk, UK

29. Department of Rheumatology, Stockport NHS Foundation Trust , Stockport, UK

30. Paediatric & Adolescent Rheumatology, Nottingham Children’s Hospital, Nottingham University Hospitals NHS Trust , Nottingham, UK

31. Department of Rheumatology, Haywood Hospital, Midlands Partnership Foundation Trust , Stoke-on-Trent, UK

32. Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals , Sheffield, UK

33. Department of Internal Medicine, State University of Zanzibar , Tunguu, Zanzibar, Tanzania

34. Department of Rheumatology, Midlands Partnership University NHS Foundation Trust , Stoke-on-Trent, UK

35. Department of Rheumatology, North Devon District Hospital, Royal Devon University , Devon, UK

36. Department of Rheumatology, Wrexham Maelor Hospital, Betsi Cadawaladr University Hospital , Wrexham, UK

37. Department of Rheumatology, NHS Tayside , Dundee, UK

38. Department of Rheumatology, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust , London, UK

Abstract

Abstract This guideline will provide up-to-date, evidence-based recommendations on the safe use of non-biologic DMARDs, also called conventional synthetic DMARDs (csDMARD), across the full spectrum of autoimmune rheumatic diseases. The guideline will update the guideline published in 2017 and will be expanded to include people of all ages. Updated information on the monitoring of DMARDs and vaccinations will be included. The guideline will be developed using the methods and processes described in the British Society for Rheumatology’s ‘Creating clinical guidelines: our protocol’, updated 2023.

Funder

British Society for Rheumatology

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/rheumap/article-pdf/8/3/rkae077/58498260/rkae077.pdf

Reference24 articles.

1. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs;Ledingham;Rheumatology (Oxford),2017

2. Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum;Nakafero;Rheumatology (Oxford),2022

3. Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and health economic evaluation;Nakafero;EClinicalMedicine,2023

4. Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK;Nakafero;BMJ,2023